tirzepatide vs cagrisema Novo Nordisk to initiate study assessing Another obesity contender just raised

or a post-market analysis of all GLP-1 RA drugs. Commenting on the study, Graham McGeown, honorary professor of physiology at Queens University Belfast, said: [These results do] suggest an association between semaglutide treatment and one form of sight-threatening optic neuropathy, but this would ideally be tested in larger studies

Ann Clin Lab Sci 45:158165 Vendrell J, El BR, Peral B et al (2011) Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance

Activation of orphan receptors by the hormone relaxin

There are a few possible reasons why tirzepatide might cause body aches